Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

JOHNSON & JOHNSON

(JNJ)
  Report
Delayed Nyse  -  01:00 2022-11-25 pm EST
177.24 USD   +0.13%
11/23Sector Update: Health Care Stocks Advancing Wednesday Afternoon
MT
11/23Sector Update: Health Care Stocks Still Advancing in Wednesday Trading
MT
11/23Sector Update: Health Care
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Valuation
Fiscal Period: January 2019 2020 2021 2022 2023 2024
Capitalization1 384 174414 310450 358463 391--
Enterprise Value (EV)1 392 583424 391452 501453 197442 830432 122
P/E ratio 25,9x28,6x21,9x22,3x20,4x19,6x
Yield 2,57%2,53%2,45%2,46%2,59%2,71%
Capitalization / Revenue 4,68x5,02x4,80x4,88x4,75x4,64x
EV / Revenue 4,78x5,14x4,83x4,77x4,54x4,33x
EV / EBITDA 14,0x15,6x12,4x13,8x12,9x12,2x
Price to Book 6,46x9,53x6,08x5,94x5,48x5,06x
Nbr of stocks (in thousands) 2 631 8722 632 5432 632 5972 614 484--
Reference price (USD) 146157171177177177
Announcement Date 01/22/202001/26/202101/25/2022---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: January 2019 2020 2021 2022 2023 2024
Net sales1 82 05982 58493 77595 04597 53999 881
EBITDA1 27 97927 14536 63432 90234 29135 538
Operating profit (EBIT)1 25 59324 57429 24429 61430 88732 174
Operating Margin 31,2%29,8%31,2%31,2%31,7%32,2%
Pre-Tax Profit (EBT)1 17 32816 49722 77625 75926 76627 842
Net income1 15 11914 71420 87820 67722 44023 719
Net margin 18,4%17,8%22,3%21,8%23,0%23,7%
EPS2 5,635,517,817,948,709,04
Dividend per Share2 3,753,984,194,374,604,81
Announcement Date 01/22/202001/26/202101/25/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: January 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales1 23 42624 02023 79123 92823 68324 256
EBITDA1 9 3059 0119 2997 8218 7668 924
Operating profit (EBIT)1 7 5367 2677 6146 7087 5747 641
Operating Margin 32,2%30,3%32,0%28,0%32,0%31,5%
Pre-Tax Profit (EBT)1 5 8625 8405 8226 030--
Net income1 --4 4584 643--
Net margin --18,7%19,4%--
EPS2 1,931,801,681,872,062,10
Dividend per Share ------
Announcement Date 04/19/202207/19/202210/18/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: January 2019 2020 2021 2022 2023 2024
Net Debt1 8 40910 0812 143---
Net Cash position1 ---10 19420 56131 269
Leverage (Debt / EBITDA) 0,30x0,37x0,06x-0,31x-0,60x-0,88x
Free Cash Flow1 19 91820 18919 75822 44826 68626 822
ROE (Net Profit / Equities) 39,1%34,9%38,2%35,1%33,8%32,2%
Shareholders' equity1 38 66442 13454 71658 88166 43473 702
ROA (Net Profit / Asset) 15,0%12,9%14,7%13,2%13,7%13,2%
Assets1 100 753114 174142 233156 083164 330179 692
Book Value Per Share2 22,616,528,229,932,335,0
Cash Flow per Share2 8,728,818,7510,811,812,6
Capex1 3 4983 3473 6523 6453 6863 871
Capex / Sales 4,26%4,05%3,89%3,84%3,78%3,88%
Announcement Date 01/22/202001/26/202101/25/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Key data
Capitalization (USD) 463 391 074 504
Net sales (USD) 93 775 000 000
Number of employees 141 700
Sales / Employee (USD) 661 785
Free-Float 83,8%
Free-Float capitalization (USD) 388 265 810 967
Avg. Exchange 20 sessions (USD) 1 219 163 348
Average Daily Capital Traded 0,26%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA